Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 11/20 | 0.72 |
| ▸ | ADORA2A | P29274 | 9/20 | 0.72 |
| ▸ | ADORA3 | P0DMS8 | 7/20 | 0.72 |
| ▸ | PDE4A | P27815 | 7/20 | 0.72 |
| ▸ | PDE4B | Q07343 | 7/20 | 0.72 |
| ▸ | PDE4C | Q08493 | 7/20 | 0.72 |
| ▸ | PDE4D | Q08499 | 7/20 | 0.72 |
| ▸ | PDE2A | O00408 | 3/20 | 0.56 |
| ▸ | PDE1A | P54750 | 2/20 | 0.56 |
| ▸ | PDE1B | Q01064 | 2/20 | 0.56 |
| ▸ | PDE1C | Q14123 | 2/20 | 0.56 |
| ▸ | CFTR | P13569 | 2/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.44 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.44 |
| ▸ | PDE5A | O76074 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | SCN1A | P35498 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL8500178 | 0.94 | ADORA2B (0.64) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| Xanthine SCHEMBL692608 | 0.91 | ADORA2B (0.61) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| SCHEMBL60158 | 0.85 | ADORA2A (0.70) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| SCHEMBL4423680 | 0.84 | ADORA2B (1.00) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| SCHEMBL27256851 | 0.83 | ADORA2B (0.68) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| SCHEMBL5451521 | 0.83 | ADORA2B (0.68) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| SCHEMBL27395394 | 0.81 | ADORA2B (1.00) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| SCHEMBL6233166 | 0.81 | ADORA2B (1.00) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| SCHEMBL4602969 | 0.81 | ADORA2B (0.73) | ADORA2BADORA2AADORA3PDE4APDE4B | |
| SCHEMBL380135 | 0.80 | ADORA2A (1.00) | ADORA2BADORA2AADORA3PDE4APDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7674 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025233983-A1 | DRUGS AND COMPOSITIONS FOR USE IN THE TREATMENT OF RETT SYNDROME | UNIVERSITA' DEGLI STUDI DI TRIESTE (IT) | 2025-11-13 | — | — | WO | claimed |
| US-20250325591-A1 | THERAPY FOR HEPATIC DISORDERS USING ADIPOSE-DERIVED MESENCHYMAL STEM CELL LINE | UNIV KEIO (JP) | 2025-10-23 | — | — | US | claimed |
| US-20250283041-A1 | METHODS FOR PRODUCING RED BLOOD CELLS | ALBERT EINSTEIN COLLEGE MEDICINE (US) | 2025-09-11 | — | — | US | claimed |
| US-20250115872-A1 | GENERATION OF BROWN ADIPOCYTES FROM HUMAN PLURIPOTENT STEM CELLS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2025-04-10 | — | — | US | claimed |
| EP-4532693-A1 | METHODS FOR PRODUCING RED BLOOD CELLS | Albert Einstein College of Medicine (US) | 2025-04-09 | — | — | EP | claimed |
| WO-2025033531-A1 | TREATMENT OF TENDON DISORDERS USING PLATELETS PRODUCED FROM ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELL LINE | 慶應義塾 | 2025-02-13 | — | — | WO | claimed |
| US-20240415893-A1 | TREATMENT FOR KNEE OSTEOARTHRITIS USING ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELL LINE | KEIO UNIVERSITY (JP) | 2024-12-19 | — | — | US | claimed |
| EP-4473093-A1 | GENERATION OF BROWN ADIPOCYTES FROM HUMAN PLURIPOTENT STEM CELLS | The Brigham and Women's Hospital, Inc. (US) | 2024-12-11 | — | — | EP | claimed |
| CN-118871570-A | Production of brown adipocytes from human pluripotent stem cells | 布里格姆妇女医院 | 2024-10-29 | — | — | CN | claimed |
| EP-4450075-A1 | THERAPY FOR HEPATIC DISORDERS USING ADIPOSE-DERIVED MESENCHYMAL STEM CELL LINE | Keio University (JP) | 2024-10-23 | — | — | EP | claimed |
| EP-0564786-A2 | Method for processing and preserving collagen-based tissues for transplantation | LIFECELL CORPORATION (US) | 1993-10-13 | — | — | EP | claimed |
| EP-0544862-A1 | Methods and compositions for the prevention, diagnosis, and treatment of inflammatory serosal diseases and related conditions | BAXTER INTERNATIONAL INC. (US) | 1993-06-09 | — | — | EP | claimed |
| WO-1992021981-A1 | METHODS AND COMPOSITIONS FOR THE PREVENTION, DIAGNOSIS, AND TREATMENT OF INFLAMMATORY SEROSAL DISEASE AND RELATED CONDITIONS | BAXTER INTERNATIONAL INC. (US) | 1992-12-10 | — | — | WO | claimed |
| EP-0308460-B1 | A COMPOSITION FOR THE TOPICAL TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION | Kabi Pharmacia AB (SE) | 1992-07-29 | — | — | EP | claimed |
| US-5079253-A | COMPOSITION FOR THE TOPICAL TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION | PHARMACIA AB (SE) | 1992-01-07 | — | — | US | claimed |
| US-4902690-A | SYNERGISTIC COMBINATION OF PHOSPHODIESTERASE INHIBITOR AND OCTOPAMINE AGONIST | THE GENERAL HOSPITAL CORPORATION (US) | 1990-02-20 | — | — | US | claimed |
| EP-0308460-A1 | A COMPOSITION FOR THE TOPICAL TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION. | PHARMACIA AB (SE) | 1989-03-29 | — | — | EP | claimed |
| US-4800081-A | CALCIUM INFLUX BLOCKER SYNERGISTIC WITH INTERFERON OR CYCLIC NUCLEOTIDE MODULATOR | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1989-01-24 | — | — | US | claimed |
| WO-1988007380-A1 | A COMPOSITION FOR THE TOPICAL TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION | PHARMACIA AB (SE) | 1988-10-06 | — | — | WO | claimed |
| WO-1987007508-A1 | METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1987-12-17 | — | — | WO | claimed |